Not rendering correctly? View this email as a web page here.
Almac Logo


Recruitment Newsletter Summer 2020 PNG 1


Supporting our people - Women in Engineering


This week, Almac celebrated International Women in Engineering Day! Staff in Almac’s Engineering departments develop and implement innovative engineering solutions for projects across the drug development lifecycle. Together we can strive to advance human health and together we can shape the world.

Find out more from some of our inspirational engineers in this short video.



Supporting our communities 


Supporting Two COVID-19 Clinical Studies in Sub-Saharan Africa

We were delighted to receive a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a  treatment for Coronavirus. This was awarded from the COVID-19 Therapeutics Accelerator, an initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard.

Read more

Donation to support COVID-19 testing      in clinical laboratories

Almac Group, together with other companies in the BioPharmaChem Ireland network, provided financial support towards the cost of a key raw material in the manufacture of Lysis buffer a critical reagent required for Covid-19 testing. The buffer, will enable support of Covid-19 testing in clinical laboratories in the Republic of Ireland and Northern Ireland.

Read more


Supporting multiple programs to accelerate COVID-19 Coronavirus treatment  

covid video



We are proud to be supporting 34 separate crucial research projects into Covid-19 treatment options for a variety of global pharmaceutical, biotech and research institutions.This is being provided by a range of services including analytical services, peptide development, expedited interactive response technology (IRT) support and clinical trial manufacturing, packaging and distribution on projects involving vaccines and potential treatments for symptoms of the coronavirus.


Supporting our clients


Introducing SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up



This summer, we announced the launch of SimplifyTM, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiency.

Read more

2018-19 Figures show Almac Group's Turnover Increased by £85M to £634M  

Alan Armstrong 2


Almac Group has reported an £85.4 million rise in turnover from £548.9 million to £634.3 million for its financial year 2018-19. During this period, the revenue increase resulted in improved pre-tax profits which were recorded at £47.6 million, up from £27.6 million for the same period the previous year. Higher exchange gains on financial activities in the year also contributed to this profit level improvement.

Read more

 Northern Ireland’s Pharmaceutical Industry will Maintain Regulatory Alignment with the EU Post-Brexit



Almac Group has welcomed confirmation from the EU’s medicines regulator, the EMA, that, post-Brexit, Northern Ireland will remain in regulatory alignment with the EU, acknowledging that EU laws, in respect of medicinal products, shall continue to apply  in Northern Ireland.This offers our clients unique, unfettered and flexible access to both the UK and European markets.

Read more

Clinical Services Launches

Tempod® 1000

Tempod Final Image


-Almac Clinical Services has just launched its innovative USB – Tempod 1000®– which captures and stores all clinical site temperature data thereby removing the administrative burden of updating manual temperature logs during clinical trials.

Read more

Most attractive employer index NI 2020

ni employer


The Index was compiled by in partnership with global employer brand specialist, Universum based on research conducted among 1476 professionals across Northern Ireland. Almac was delighted to be included in this index at number 13!

Read more


Supporting students using virtual Outreach

This week, over 150 post-primary students joined our webinar - "Life in the Pharmaceutical Industry: Which Course? What Career?"

Our panellists, Dr Frances Weldon, Gemma Logan, Dawn Thompson, Simon Taylor & Sinead O'Connor gave an overview of Almac’s activities and careers across the drug development lifecycle and facilitated a Q&A session about various roles and education pathways.


My Post


Banner Newsletter PNG


Twitter Logo Linked In Logo Vimeo Logo PNG for New Guidelines.png

Please view our Privacy Policy which explains how and why we may use your personal information and the steps we take to protect it.